This includes vials, ampoules, cartridges, and pre-filled syringes (PFS) for both liquid and lyophilised formulations

Sovereign Pharma, a leader in high-quality injectable manufacturing, proudly announces its milestone: EU approval for aseptic and terminally sterilised products, including vials, ampoules, cartridges, and pre-filled syringes (PFS) for both liquid and lyophilised formulations. This achievement is a significant step in the company’s commitment to quality, safety, and global healthcare excellence.

The EU approval joins ANVISA (Brazil) and MHRA (UK) certifications, all three secured over a year. With these three prestigious approvals, Sovereign Pharma has strengthened its global presence, ensuring its products meet the highest international regulatory standards.

“At Sovereign Pharma, quality is not just a standard—it’s the foundation of everything we do,” said Kairus Dadachanji, Founder of Sovereign Pharma. “This EU approval reaffirms our dedication to manufacturing excellence, ensuring that every vial, ampoule, cartridge, and syringe we produce meets the strictest levels of safety, efficacy, and reliability.”